Scarica l'app Stockscreener
0.6575
2.56%
0.0164
Precedente Chiudi:
$0.6411
Aprire:
$0.64
Volume 24 ore:
1,755
Relative Volume:
0.05
Capitalizzazione di mercato:
$3.72M
Reddito:
$14.64M
Utile/perdita netta:
$-13.74M
Rapporto P/E:
-0.0904
EPS:
-7.27
Flusso di cassa netto:
$-5.04M
1 W Prestazione:
+1.81%
1M Prestazione:
+15.35%
6M Prestazione:
-7.41%
1 anno Prestazione:
-69.13%
Intervallo 1D:
$0.64
$0.64
Intervallo di 1 settimana:
$0.6377
$0.70
Portata 52W:
$0.3611
$2.25
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Nome
Novabay Pharmaceuticals Inc
Settore
Industria
Telefono
510-899-8800
Indirizzo
2000 Powell Street, Suite 1150, Emeryville, CA
Confronta NBY con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
0.64 | 3.90M | 14.64M | -13.74M | -5.04M | -7.27 |
|
VRTX
Vertex Pharmaceuticals Inc
|
475.69 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
571.91 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
326.40 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.84 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
296.02 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-09-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-07-06 | Reiterato | H.C. Wainwright | Buy |
| 2017-11-15 | Reiterato | Laidlaw | Buy |
| 2017-06-05 | Iniziato | ROTH Capital | Buy |
| 2017-03-27 | Iniziato | Laidlaw | Buy |
| 2017-02-06 | Iniziato | Rodman & Renshaw | Buy |
| 2016-03-07 | Downgrade | Maxim Group | Buy → Hold |
| 2015-12-14 | Reiterato | Maxim Group | Buy |
| 2015-04-30 | Ripresa | Maxim Group | Buy |
| 2013-03-06 | Iniziato | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Iniziato | Dawson James | Speculative Buy |
Mostra tutto
Novabay Pharmaceuticals Inc Borsa (NBY) Ultime notizie
NovaBay Pharmaceuticals Inc. Stock Analysis and ForecastHigh-yield investments - jammulinksnews.com
What drives NovaBay Pharmaceuticals Inc. stock priceFree Technical Analysis Support - jammulinksnews.com
What analysts say about NovaBay Pharmaceuticals Inc. stockExceptional growth trajectory - jammulinksnews.com
Is NovaBay Pharmaceuticals Inc. a good long term investmentMarket-beating performance - printweek.in
When is the best time to buy NovaBay Pharmaceuticals Inc. stockFree Real-Time Market Predictions - beatles.ru
Why NovaBay Pharmaceuticals Inc. stock attracts strong analyst attentionMinimized Risk Maximum Return - Newser
What makes NovaBay Pharmaceuticals Inc. stock price move sharplyBreakout Setup Scanner - Newser
How NovaBay Pharmaceuticals Inc. stock performs during market volatilityReturn Optimized Trade Insights - Newser
StockNews.com Begins Coverage on NovaBay Pharmaceuticals (NYSE:NBY) - Defense World
NovaBay fails to gain shareholder approval for dissolution - MSN
NovaBay Pharmaceuticals (NYSE:NBY) Now Covered by Analysts at StockNews.com - Defense World
CNS Pharma Stock Price, Quotes and Forecasts | NASDAQ:CNSP - Benzinga
Press Release Distribution & PR Platform - ACCESS Newswire
NovaBay Pharmaceuticals approves liquidation plan By Investing.com - Investing.com Canada
NovaBay Pharmaceuticals approves liquidation plan - Investing.com
Poplar Point Capital Partners acquires $39,503 in NovaBay shares - Investing.com Australia
Poplar Point Capital Partners increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com South Africa
Poplar Point Capital increases stake in NovaBay Pharmaceuticals - Investing.com Australia
Massive Stock Acquisition: Poplar Point Capital Partners Bets Big on NovaBay Pharma! - TipRanks
Poplar Point Capital Partners acquires $29,857 in NovaBay shares - Investing.com Australia
Poplar Point Capital increases stake in NovaBay Pharmaceuticals By Investing.com - Investing.com India
Poplar Point Capital Partners acquires $39,503 in NovaBay shares By Investing.com - Investing.com India
Poplar Point Capital Partners acquires $29,857 in NovaBay shares By Investing.com - Investing.com Canada
Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions - Investing.com
Novabay Pharmaceuticals sees $15,966 in recent stock acquisitions By Investing.com - Investing.com UK
NovaBay Pharmaceuticals sees $67,700 stock acquisition by Poplar Point Capital - Investing.com India
Novabay Pharmaceuticals Inc Azioni (NBY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.15%
0.50%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):